Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer.

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

[8] Respiratory syncytial virus (RSV) is a highly contagious and potentially serious ... At the heart of this is the company's R&D focus on the science of the immune system, human genetics and ...

A viral outbreak in Kolkata is causing dengue-like symptoms including high fever, joint pain, and rashes. Despite extensive testing, few patients are testing positive for dengue or malaria, leading ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringesCanada is the fourth jurisdiction to approve mRESVIA ...

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of ...

Canada reports its first presumptive human H5 bird flu case ... marking the first mRNA-based authorized vaccine for ...

The MERA Vaccines Summit brought together more than 180 physicians and healthcare professionals to Dubai to discuss a r ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...